151 related articles for article (PubMed ID: 32816071)
21. [Tofacitinib].
Döker S; Dewenter M; El-Armouche A
Dtsch Med Wochenschr; 2014 May; 139(19):1003-8. PubMed ID: 24782154
[TBL] [Abstract][Full Text] [Related]
22. Early use of anakinra in adult-onset Still's disease myocarditis.
Piel-Julian ML; Moulis G; Fournier P; Dupont R; Geiger D; Astudillo L; Faurie T; Pozzo J; Petermann A; Lairez O; Pugnet G; Sailler L
Scand J Rheumatol; 2018 Nov; 47(6):511-512. PubMed ID: 29291663
[No Abstract] [Full Text] [Related]
23. Adult Still's disease with myocarditis and peritonitis.
Hosaka S; Takashina N; Ishikawa A; Kondo H; Kashiwazaki S
Intern Med; 1992 Jun; 31(6):812-5. PubMed ID: 1392186
[TBL] [Abstract][Full Text] [Related]
24. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
25. Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever.
Gök K; Cengiz G; Erol K; Ozgocmen S
Acta Reumatol Port; 2017; 42(1):88-90. PubMed ID: 28371574
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
Mod Rheumatol; 2014 Nov; 24(6):1030-1. PubMed ID: 24313885
[No Abstract] [Full Text] [Related]
27. [Renal amyloidosis complicating adult onset Still's disease: about three cases].
Sameh M; Raida BS; Yosra C; Moez J; Saida G; Khawla K; Jamil H; Zouhir B
Pan Afr Med J; 2019; 32():158. PubMed ID: 31303928
[TBL] [Abstract][Full Text] [Related]
28. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
29. [Adult onset Still's disease as a diagnostics challenge in case of fever of unknown origin].
Debski M; Stepniewski P; Wróbel M
Pol Merkur Lekarski; 2013 Jan; 34(199):45-8. PubMed ID: 23488285
[TBL] [Abstract][Full Text] [Related]
30. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A in the treatment of adult Still's disease.
Shojania K; Chalmers A; Rangno K
J Rheumatol; 1995 Jul; 22(7):1391-2. PubMed ID: 7562781
[TBL] [Abstract][Full Text] [Related]
32. JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.
Tanaka Y; Yamaoka K
Mod Rheumatol; 2013 May; 23(3):415-24. PubMed ID: 23212593
[TBL] [Abstract][Full Text] [Related]
33. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
Forestier E; Pasquali JL
Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837
[No Abstract] [Full Text] [Related]
34. A case of adult onset Still's disease with flare of arthritis.
Sen K; Ghosh UC; Mukherjee AK; Ghosal A; Pandey UK
J Indian Med Assoc; 2013 Feb; 111(2):132-4. PubMed ID: 24003576
[TBL] [Abstract][Full Text] [Related]
35. Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease.
Fortna RR; Gudjonsson JE; Seidel G; Dicostanzo D; Jacobson M; Kopelman M; Patel RM
J Cutan Pathol; 2010 Sep; 37(9):932-7. PubMed ID: 20546088
[TBL] [Abstract][Full Text] [Related]
36. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
Orsolini G; Bertoldi I; Rossini M
Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
[TBL] [Abstract][Full Text] [Related]
37. [Severe hepatitis in a patient with adult-onset Still's disease treated with anakinra].
Diallo A; Mekinian A; Boukari L; Mouas H; Zamy M; Nahon P; Gérin M; Fain O
Rev Med Interne; 2013 Mar; 34(3):168-70. PubMed ID: 23182291
[TBL] [Abstract][Full Text] [Related]
38. Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years.
Pope J; Bessette L; Jones N; Fallon L; Woolcott J; Gruben D; Crooks M; Gold D; Haraoui B
Rheumatology (Oxford); 2020 Mar; 59(3):568-574. PubMed ID: 31410469
[TBL] [Abstract][Full Text] [Related]
39. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
Liu LY; Strassner JP; Refat MA; Harris JE; King BA
J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
[TBL] [Abstract][Full Text] [Related]
40. Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
Pérez-Román DI; Ortiz-Haro AB; Ruiz-Medrano E; Contreras-Yáñez I; Pascual-Ramos V
Rheumatol Int; 2018 Apr; 38(4):599-606. PubMed ID: 29264637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
